Figure 2

Kaplan-Meier curves for patient survival. pGSK-3β-positive carcinomas showed a more favorable prognosis than pGSK-3β-negative carcinomas (P < 0.001, A). Survival rate was dependent on pGSK-3β expression in early-stage tumors (P = 0.034, B), but not in late-stage tumors (P = 0.918, C).